Physician Wealth Advisors Inc. Acquires 3,100 Shares of Axon Enterprise, Inc $AXON

Physician Wealth Advisors Inc. increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 851.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,464 shares of the biotechnology company’s stock after acquiring an additional 3,100 shares during the period. Physician Wealth Advisors Inc.’s holdings in Axon Enterprise were worth $1,464,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Rockefeller Capital Management L.P. grew its stake in shares of Axon Enterprise by 53.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after purchasing an additional 4,002 shares during the period. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Axon Enterprise by 122,993.6% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock worth $195,036,000 after buying an additional 461,226 shares in the last quarter. B. Metzler seel. Sohn & Co. AG bought a new position in shares of Axon Enterprise during the 2nd quarter worth approximately $3,854,000. Arrowstreet Capital Limited Partnership bought a new position in shares of Axon Enterprise during the 1st quarter worth approximately $15,067,000. Finally, Brown Lisle Cummings Inc. lifted its position in shares of Axon Enterprise by 97,231.4% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock worth $19,098,000 after buying an additional 34,031 shares during the period. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on AXON. Morgan Stanley boosted their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Barclays increased their price objective on Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. Finally, Raymond James Financial set a $675.00 target price on shares of Axon Enterprise in a research note on Thursday, October 15th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $707.07.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 9,605 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 47,397 shares of company stock worth $26,722,984. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 2.5%

Shares of NASDAQ:AXON opened at $392.64 on Wednesday. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The firm has a market cap of $31.90 billion, a P/E ratio of 162.92, a P/E/G ratio of 7.21 and a beta of 1.44. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $764.02. The company’s 50-day moving average price is $492.46 and its two-hundred day moving average price is $474.34.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same period in the previous year, the firm posted $2.12 earnings per share. The company’s revenue was up 35.3% on a year-over-year basis. As a group, research analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is expected to report third-quarter results soon, with analysts anticipating a substantial year-over-year increase in earnings per share. The earnings preview may be supporting optimism about continued revenue and profit growth. Earnings Preview: What to Expect From Axon Enterprise’s Report
• Positive Sentiment: Bloomington approved an expanded agreement with Axon for policing technology, while the Reno City Council is set to vote on a proposed $22 million deal. Additional municipal contracts could reinforce Axon’s recurring-revenue model and strengthen demand for its connected hardware and cloud software. Bloomington council OKs expanded agreement with Axon for policing technology City of Reno council to vote on $22M Axon tech deal
• Positive Sentiment: Commentary from The Motley Fool describes Axon as a potential buy after a roughly 54% decline, arguing that recent pressure appears largely short-term and that the company retains a dominant position in public safety. Down 54%, This Tech Stock Looks Like a Buy With or Without AI
• Neutral Sentiment: Piper Sandler maintained an “overweight” rating but reduced its AXON price target from $732 to $561. The target cut signals more cautious near-term expectations, although it still implies significant potential upside based on the cited trading level.
• Neutral Sentiment: A comparison with Arista Networks emphasizes Axon’s integrated hardware-and-cloud platform and strong public-safety market position, but it is an opinion piece rather than a new company-specific catalyst. Arista Networks vs. Axon Enterprise
• Neutral Sentiment: Reports concerning an “Axon Graphite” spin-out by Lithium Energy and a reverse stock split by Axonex AI Group are unrelated to Axon Enterprise, Inc. (AXON) and should not affect its shares.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.